Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Supha Pharmachem's book value per share for the quarter that ended in Sep. 2025 was ₹1.19.
During the past 12 months, Supha Pharmachem's average Book Value Per Share Growth Rate was 50.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 107.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 81.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 29.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Supha Pharmachem was 123.10% per year. The lowest was 0.00% per year. And the median was 12.60% per year.
Supha Pharmachem's current price is ₹0.28. Its book value per share for the quarter that ended in Sep. 2025 was ₹1.19. Hence, today's PB Ratio of Supha Pharmachem is 0.23.
During the past 11 years, the highest P/B Ratio of Supha Pharmachem was 137.17. The lowest was 0.23. And the median was 2.98.
Good Sign:
Supha Pharmachem Ltd stock PB Ratio (=0.23) is close to 10-year low of 0.23.
Supha Pharmachem (BOM:539561) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Supha Pharmachem Book Value per Share Related Terms
Supha Pharmachem Book Value per Share Historical Data
* Premium members only.
The historical data trend for Supha Pharmachem's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539561 vs ZTS: Book Value per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Supha Pharmachem's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supha Pharmachem PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Supha Pharmachem's PB Ratio distribution charts can be found below:
* The bar in red indicates where Supha Pharmachem's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Supha Pharmachem (BOM:539561) has a Book Value per Share of ₹1.19 as of Sep. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Supha Pharmachem and its competitors.
Is Supha Pharmachem's Book Value per Share too high?
Supha Pharmachem's current Book Value per Share is ₹1.19. Overall, Supha Pharmachem has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's Book Value per Share compare to ZTS?
Supha Pharmachem's Book Value per Share of ₹1.19 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Supha Pharmachem and its competitors. Supha Pharmachem's current Book Value per Share is ₹1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.51, compared to a current price of ₹0.28 — trading 81.5% below its estimated fair value. The current Book Value per Share is ₹1.19. Supha Pharmachem's overall GF Score™ is 54/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current Book Value per Share is ₹1.19 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supha Pharmachem (BOM:539561) Overvalued in 2026?
Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued.
The current stock price of ₹0.28 is trading 81.5% below its estimated GF Value™ of ₹1.51.
GuruFocus considers Supha Pharmachem to be Possible Value Trap.
Key valuation signals for BOM:539561:
Book Value per Share: ₹1.19
GF Value™: ₹1.51 vs. price of ₹0.28 (81.5% below fair value)
No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
54GF Score
Get the complete analysis for BOM:539561
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539561 has been successfully added to your 
